SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards, providing insights based on real-world drug pricing data.

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

which is in line with the median for all price increases last year. The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts. Larger drug ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.